APA (7th ed.) Citation

L, A., C, P., M, F., L, B., V, D., R, C., . . . C, B. (2021). Preclinical Development of FA5, a Novel AMP-Activated Protein Kinase (AMPK) Activator as an Innovative Drug for the Management of Bowel Inflammation. International journal of molecular sciences, 22(12), . https://doi.org/10.3390/ijms22126325

Chicago Style (17th ed.) Citation

L, Antonioli, et al. "Preclinical Development of FA5, a Novel AMP-Activated Protein Kinase (AMPK) Activator as an Innovative Drug for the Management of Bowel Inflammation." International Journal of Molecular Sciences 22, no. 12 (2021). https://doi.org/10.3390/ijms22126325.

MLA (9th ed.) Citation

L, Antonioli, et al. "Preclinical Development of FA5, a Novel AMP-Activated Protein Kinase (AMPK) Activator as an Innovative Drug for the Management of Bowel Inflammation." International Journal of Molecular Sciences, vol. 22, no. 12, 2021, https://doi.org/10.3390/ijms22126325.